Back to Endocrinology
Endocrinologyv1993Evidence-Based

MACIS Score (Papillary Thyroid Cancer)

Prognostic score for papillary thyroid carcinoma: Metastasis, Age, Completeness, Invasion, Size.

Clinical Input Parameters

years
Range: 10 — 100 years
cm
Range: 0.1 — 20 cm
Clinical Assessment
Awaiting Parameters
macis
—points
Ready to Calculate

Awaiting Clinical Input

Enter the clinical input parameters on the left and click Run Clinical Assessment to evaluate this medical calculator with deterministic clinical scoring.

Open in Web App
Clinical decision support tool for licensed medical practitioners. Confirm independently before prescribing or clinical action.

When & Why to Use

The MACIS Score (Papillary Thyroid Cancer) is utilized in clinical practice for risk stratification, diagnostic probability estimation, and treatment decision-making within endocrinology.

Use this tool during initial patient intake, emergency department workup, or bedside assessment when objective clinical scoring is required to guide management or admission decisions.

Clinical Formula & Scoring Logic

MACIS = 3.1 (age<=39) or 0.08xage + 0.3xsize(cm) + 1 (if incomplete resection) + 1 (if invasive) + 3 (if distant mets).

Evidence & Literature Citations

  1. Hay ID, Bergstralh EJ, Goellner JR, et al. Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery. 1993;114(6):1050-1058.

Score Interpretation Ranges

Low risk0 – 6 pts

<6

Intermediate6 – 7 pts

6-6.99

High7 – 8 pts

7-7.99

Very high8 – 50 pts

>=8

Need Clinical Suite Access?

Run this calculator with patient history, laboratory integration, and drug interaction safety checks on the DexaMed clinician app.

Open in Web App

Clinical Decision Support (CDS) Notice & Legal Disclaimer

This medical calculator and its scoring interpretation are provided strictly for licensed healthcare professionals and medical trainees as an educational and clinical decision support instrument. It does not replace independent clinical judgment, comprehensive patient history, physical examination, or attending physician oversight. Not FDA-cleared as an autonomous diagnostic medical device. Read the full DexaMed Medical Disclaimer.